161 related articles for article (PubMed ID: 24039913)
1. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
Benton DC; Garbarg M; Moss GW
PLoS One; 2013; 8(9):e73328. PubMed ID: 24039913
[TBL] [Abstract][Full Text] [Related]
2. Allosteric block of KCa2 channels by apamin.
Lamy C; Goodchild SJ; Weatherall KL; Jane DE; Liégeois JF; Seutin V; Marrion NV
J Biol Chem; 2010 Aug; 285(35):27067-27077. PubMed ID: 20562108
[TBL] [Abstract][Full Text] [Related]
3. Small-conductance Ca(2+)-activated K(+) channels: Heterogeneous affinity in rat brain structures and cognitive modulation by specific blockers.
Mpari B; Sreng L; Regaya I; Mourre C
Eur J Pharmacol; 2008 Jul; 589(1-3):140-8. PubMed ID: 18561910
[TBL] [Abstract][Full Text] [Related]
4. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
5. Expression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states.
Siddiqui T; Lively S; Ferreira R; Wong R; Schlichter LC
PLoS One; 2014; 9(8):e106087. PubMed ID: 25148577
[TBL] [Abstract][Full Text] [Related]
6. Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db Mice.
Comerma-Steffensen S; Prat-Duran J; Mogensen S; Fais R; Pinilla E; Simonsen U
J Sex Med; 2022 May; 19(5):697-710. PubMed ID: 35321830
[TBL] [Abstract][Full Text] [Related]
7. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Chantome A; Girault A; Potier M; Collin C; Vaudin P; Pagès JC; Vandier C; Joulin V
Exp Cell Res; 2009 Dec; 315(20):3620-30. PubMed ID: 19646982
[TBL] [Abstract][Full Text] [Related]
8. The interactions of apamin and tetraethylammonium are differentially affected by single mutations in the pore mouth of small conductance calcium-activated potassium (SK) channels.
Dilly S; Philippart F; Lamy C; Poncin S; Snyders D; Seutin V; Liégeois JF
Biochem Pharmacol; 2013 Feb; 85(4):560-9. PubMed ID: 23270990
[TBL] [Abstract][Full Text] [Related]
9. Small-conductance Ca
Tenma T; Mitsuyama H; Watanabe M; Kakutani N; Otsuka Y; Mizukami K; Kamada R; Takahashi M; Takada S; Sabe H; Tsutsui H; Yokoshiki H
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H262-H272. PubMed ID: 29631373
[TBL] [Abstract][Full Text] [Related]
10. Maurotoxin: a potent inhibitor of intermediate conductance Ca2+-activated potassium channels.
Castle NA; London DO; Creech C; Fajloun Z; Stocker JW; Sabatier JM
Mol Pharmacol; 2003 Feb; 63(2):409-18. PubMed ID: 12527813
[TBL] [Abstract][Full Text] [Related]
11. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels.
Gentles RG; Grant-Young K; Hu S; Huang Y; Poss MA; Andres C; Fiedler T; Knox R; Lodge N; Weaver CD; Harden DG
Bioorg Med Chem Lett; 2008 Oct; 18(19):5316-9. PubMed ID: 18774291
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels.
Sones WR; Leblanc N; Greenwood IA
Br J Pharmacol; 2009 Sep; 158(2):521-31. PubMed ID: 19645713
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
Brown BM; Shim H; Christophersen P; Wulff H
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271
[TBL] [Abstract][Full Text] [Related]
14. Correspondences between the binding characteristics of a non-natural peptide, Lei-Dab7, and the distribution of SK subunits in the rat central nervous system.
Aidi-Knani S; Pezard L; Mpari B; Ben Hamida J; Sabatier JM; Mourre C; Regaya I
Eur J Pharmacol; 2015 Apr; 752():106-11. PubMed ID: 25704615
[TBL] [Abstract][Full Text] [Related]
15. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
[TBL] [Abstract][Full Text] [Related]
16. The small neurotoxin apamin blocks not only small conductance Ca
Voos P; Yazar M; Lautenschläger R; Rauh O; Moroni A; Thiel G
Eur Biophys J; 2017 Sep; 46(6):517-523. PubMed ID: 28108814
[TBL] [Abstract][Full Text] [Related]
17. Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells.
Dale TJ; Cryan JE; Chen MX; Trezise DJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):470-7. PubMed ID: 12382077
[TBL] [Abstract][Full Text] [Related]
18. Ondansetron blocks wild-type and p.F503L variant small-conductance Ca
Ko JS; Guo S; Hassel J; Celestino-Soper P; Lynnes TC; Tisdale JE; Zheng JJ; Taylor SE; Foroud T; Murray MD; Kovacs RJ; Li X; Lin SF; Chen Z; Vatta M; Chen PS; Rubart M
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H375-H388. PubMed ID: 29677462
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).
Christophersen P; Wulff H
Channels (Austin); 2015; 9(6):336-43. PubMed ID: 26217968
[TBL] [Abstract][Full Text] [Related]
20. Charybdotoxin-sensitive small conductance K(Ca) channel activated by bradykinin and substance P in endothelial cells.
Sollini M; Frieden M; Bény JL
Br J Pharmacol; 2002 Aug; 136(8):1201-9. PubMed ID: 12163354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
